Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Pulmonx (LUNG) Accumulated Depreciation & Amortization (2019 - 2025)

Pulmonx has reported Accumulated Depreciation & Amortization over the past 7 years, most recently at $6.6 million for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 16.18% to $6.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.6 million through Dec 2025, up 16.18% year-over-year, with the annual reading at $6.6 million for FY2025, 16.18% up from the prior year.
  • Accumulated Depreciation & Amortization was $6.6 million for Q4 2025 at Pulmonx, up from $6.6 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $6.6 million in Q4 2025 and troughed at $1.9 million in Q1 2021.
  • The 5-year median for Accumulated Depreciation & Amortization is $4.5 million (2023), against an average of $4.3 million.
  • Year-over-year, Accumulated Depreciation & Amortization surged 58.54% in 2022 and then increased 11.61% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $2.2 million in 2021, then surged by 58.54% to $3.6 million in 2022, then soared by 36.53% to $4.9 million in 2023, then grew by 17.9% to $5.7 million in 2024, then rose by 16.18% to $6.6 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Accumulated Depreciation & Amortization are $6.6 million (Q4 2025), $6.6 million (Q3 2025), and $6.3 million (Q2 2025).